GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
ZVNIX
Price
$31.80
Change
-$2.34 (-6.85%)
Updated
Apr 3 closing price
Net Assets
116.26M
Ad is loading...

GFACX vs ZVNIX

Header iconGFACX vs ZVNIX Comparison
Open Charts GFACX vs ZVNIXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
Zevenbergen Growth Institutional
Price$31.80
Change-$2.34 (-6.85%)
VolumeN/A
Net Assets116.26M
GFACX vs ZVNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. ZVNIX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and ZVNIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. ZVNIX (116M). GFACX (0.00) and ZVNIX (0.00) have matching dividends . GFACX was incepted earlier than ZVNIX: GFACX (24 years) vs ZVNIX (10 years). GFACX (1.36) is less costly to investors than ZVNIX (1.22). GFACX is a more actively managed with annual turnover of: 25.00 vs. ZVNIX (13.62). GFACX has a lower initial minimum investment than ZVNIX: GFACX (250) vs ZVNIX (50000). ZVNIX annual gain was more profitable for investors over the last year : 7.09 vs. GFACX (-1.75). ZVNIX return over 5 years is better than : 94.42 vs. GFACX (59.73).
GFACXZVNIXGFACX / ZVNIX
Total Expense Ratio1.361.00136%
Annual Report Gross Expense Ratio1.361.22111%
Fund Existence24 years10 years-
Gain YTD-5.003-12.07841%
Front LoadN/AN/A-
Min. Initial Investment250500001%
Min. Initial Investment IRAN/AN/A-
Net Assets280B116M241,379%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.757.09-25%
Returns for 3 years0.634.3714%
Returns for 5 years59.7394.4263%
Returns for 10 years44.46N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences